Search research articles
Contact Us
Filters
Showing results (191-200 of 269) with videos related to
Page
of 27
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 16, 2025
Bowel Urgency in Crohn's Disease: Effects of Mirikizumab in a Randomized Controlled Phase 3 Study
Vipul Jairath, Geert D'Haens, Bruce E Sands, et al.
Journal of Crohn'S & Colitis
|
July 24, 2025
Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients with Moderately to Severely Active Crohn's Disease: 2-Year Results from the U-ENDURE Long-Term Extension Study
Edward V Loftus, Geert D'Haens, Edouard Louis, et al.
The American Journal of Gastroenterology
|
January 8, 2025
Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial
Bruce E Sands, David T Rubin, Edward V Loftus, et al.
Journal of Crohn'S & Colitis
|
November 7, 2023
Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes
Séverine Vermeire, Jurij Hanzel, Mark Löwenberg, et al.
Mabs
|
February 9, 2021
Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters
HoUng Kim, Rieke Alten, Fraser Cummings, et al.
Journal of Crohn'S & Colitis
|
July 26, 2021
Systematic Review and Meta-Analysis: Clinical, Endoscopic, Histological and Safety Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis
Rocio Sedano, Malcolm Hogan, Tran M Nguyen, et al.
The New England Journal of Medicine
|
April 3, 2009
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer
Eric Van Cutsem, Claus-Henning Köhne, Erika Hitre, et al.
Gut
|
February 18, 2017
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
Julian Panés, William J Sandborn, Stefan Schreiber, et al.
Therapeutic Advances in Gastroenterology
|
February 27, 2025
Tryptophan metabolites profile predict remission with dietary therapy in pediatric Crohn's disease
Rotem Sigall Boneh, Nikki van der Kruk, Eytan Wine, et al.
Journal of Crohn'S & Colitis
|
July 8, 2016
Effect of Standardised Scoring Conventions on Inter-rater Reliability in the Endoscopic Evaluation of Crohn's Disease
Elena Dubcenco, Guangyong Zou, Larry Stitt, et al.
Page
of 27
Search research articles
Search
Showing results (191-200 of 269) with videos related to
Sort By:
Page
of 27
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 16, 2025
Bowel Urgency in Crohn's Disease: Effects of Mirikizumab in a Randomized Controlled Phase 3 Study
Vipul Jairath, Geert D'Haens, Bruce E Sands, et al.
Journal of Crohn'S & Colitis
|
July 24, 2025
Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients with Moderately to Severely Active Crohn's Disease: 2-Year Results from the U-ENDURE Long-Term Extension Study
Edward V Loftus, Geert D'Haens, Edouard Louis, et al.
The American Journal of Gastroenterology
|
January 8, 2025
Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial
Bruce E Sands, David T Rubin, Edward V Loftus, et al.
Journal of Crohn'S & Colitis
|
November 7, 2023
Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes
Séverine Vermeire, Jurij Hanzel, Mark Löwenberg, et al.
Mabs
|
February 9, 2021
Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters
HoUng Kim, Rieke Alten, Fraser Cummings, et al.
Journal of Crohn'S & Colitis
|
July 26, 2021
Systematic Review and Meta-Analysis: Clinical, Endoscopic, Histological and Safety Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis
Rocio Sedano, Malcolm Hogan, Tran M Nguyen, et al.
The New England Journal of Medicine
|
April 3, 2009
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer
Eric Van Cutsem, Claus-Henning Köhne, Erika Hitre, et al.
Gut
|
February 18, 2017
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
Julian Panés, William J Sandborn, Stefan Schreiber, et al.
Therapeutic Advances in Gastroenterology
|
February 27, 2025
Tryptophan metabolites profile predict remission with dietary therapy in pediatric Crohn's disease
Rotem Sigall Boneh, Nikki van der Kruk, Eytan Wine, et al.
Journal of Crohn'S & Colitis
|
July 8, 2016
Effect of Standardised Scoring Conventions on Inter-rater Reliability in the Endoscopic Evaluation of Crohn's Disease
Elena Dubcenco, Guangyong Zou, Larry Stitt, et al.
Page
of 27